Gibson Dunn & Crutcher advised Merck on the transaction and Wilson Sonsini Goodrich & Rosati advised LaNova Medicines. Merck (NYSE: MRK), known as MSD outside of...
Merck’s License Agreement with LaNova
Merck’s Acquisition of Eyebiotech
Skadden advised Eyebiotech Limited, while Gibson, Dunn & Crutcher advised Merck the deal. Merck, known as MSD outside of the United States and Canada, and Eyebiotech...
Merck’s Acquisition of Caraway Therapeutics, Inc.
Gibson, Dunn & Crutcher LLP advised Merck on its acquisition of Caraway Therapeutics, Inc. Merck (NYSE: MRK), known as MSD outside of the United States and...
Daiichi Sankyo and Merck’s Global Development and Commercialization Collaboration for Three Daiichi Sankyo DXd ADCs
Gibson, Dunn & Crutcher LLP is advising Merck on the agreement. Daiichi Sankyo (TSE: 4568) and Merck (known as MSD outside of the United States and...
ExxonMobil’s $64.5 Billion Acquisition of Pioneer Natural Resources
Citi acted as lead financial advisor, Centerview Partners as financial advisor, and Davis Polk & Wardwell as legal advisor to ExxonMobil. Goldman Sachs, Morgan Stanley, Petrie...
Patterson-UTI’s $370 Million Acquisition of Ulterra
Gibson, Dunn & Crutcher LLP is advising Patterson-UTI Energy, Inc., while Kirkland & Ellis is advising Blackstone Energy Partners in the transaction. Patterson-UTI Energy, Inc. (NASDAQ:PTEN)...
NexTier’s $5.4 Billion Merger of Equals With Patterson-UTI
Kirkland & Ellis LLP is serving as legal advisor to NexTier, while Gibson, Dunn & Crutcher LLP is serving as legal advisor to Patterson-UTI. Patterson-UTI Energy,...